Overview

• The study involved 174 adults with clinical depression who were treated using a Flow Neuroscience headset over a 10-week period.
• Participants using the active headset experienced a remission rate of 44.9%, compared to 21.8% in the placebo group.
• The non-invasive technique, transcranial direct current stimulation (tDCS), stimulates brain areas linked to depression with a weak electrical current.
• Researchers noted the treatment's effectiveness and safety, with no serious side effects reported.
• Experts suggest this could provide a new alternative for patients not responding to traditional antidepressants or therapy.